ASX News Health Care Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome Neuren has confirmed it's received "positive" FDA responses for its Phase III trial to treat children… Jonathon Davidson2 mins07 October 2024 10:33 (AEDT)